P

Inventor

SINGER CLAUDE

IL36 patents
⚠️ This page may combine multiple inventors who share the name “SINGER CLAUDE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

TEVA PHARMA

27 patents
US6365574B2Apr 2, 2002

Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof

TEVA PHARMA59 citations96
US6500987B1Dec 31, 2002

Sertraline hydrochloride polymorphs

TEVA PHARMA38 citations95
US6255526B1Jul 3, 2001

Preparation of gabapentin

TEVA PHARMA58 citations95
US6600073B1Jul 29, 2003

Methods for preparation of sertraline hydrochloride polymorphs

TEVA PHARMA14 citations92
US6586576B2Jul 1, 2003

Preparation method of azithromycin hydrates

TEVA PHARMA21 citations92
US6452054B2Sep 17, 2002

Sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and methods of using them

TEVA PHARMA36 citations92
US6531509B2Mar 11, 2003

Stable gabapentin containing more than 20 ppm of chlorine ion

TEVA PHARMA19 citations91
US6849120B2Feb 1, 2005

Oxidation method for preparing highly pure modafinil, crystalline forms of modafinil, and methods of preparing the crystalline forms

TEVA PHARMA24 citations90
US6764997B2Jul 20, 2004

Stabilized azithromycin compositions

TEVA PHARMA29 citations87
US6858652B2Feb 22, 2005

Sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and methods of using them

TEVA PHARMA5 citations74
US6909004B2Jun 21, 2005

Method for the purification of lansoprazole

TEVA PHARMA5 citations73
US6861426B2Mar 1, 2005

Crystal forms of lamotrigine and processes for their preparations

TEVA PHARMA7 citations71
US7060837B2Jun 13, 2006

Method for the purification of lansoprazole

TEVA PHARMA3 citations62
US7022859B2Apr 4, 2006

Method for the purification of lansoprazole

TEVA PHARMA2 citations62
US7022881B2Apr 4, 2006

Sertraline hydrochloride polymorphs

TEVA PHARMA3 citations62
US6576764B2Jun 10, 2003

Synthesis and crystallization of piperazine ring-containing compounds

TEVA PHARMA2 citations62
US6545149B2Apr 8, 2003

Synthesis and crystallization of piperazine ring-containing compounds

TEVA PHARMA3 citations62
US7390807B2Jun 24, 2008

Crystal forms of lamotrigine and processes for their preparations

TEVA PHARMA3 citations60
US7462737B2Dec 9, 2008

Pregabalin free of isobutylglutaric acid and a process for preparation thereof

TEVA PHARMA2 citations58
US7683080B2Mar 23, 2010

Stable iansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol

TEVA PHARMA0 citations51
US7678816B2Mar 16, 2010

Method of stabilizing lansoprazole

TEVA PHARMA0 citations51
US7622588B2Nov 24, 2009

Method for the purification of lansoprazole

TEVA PHARMA0 citations51
US5302741AApr 12, 1994

Optical resolution of threo-2-hydroxy-3-(2-aminophenylthio)-3-(4-methoxyphenyl)-propionic acid

TEVA PHARMA1 citations51
US7763749B2Jul 27, 2010

Method for the preparation of Pregabalin and salts thereof

TEVA PHARMA0 citations50
US7683177B2Mar 23, 2010

Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole

TEVA PHARMA0 citations50
US7678938B2Mar 16, 2010

Optical resolution of 3-carbamoylmethyl-5-methyl hexanoic acid

TEVA PHARMA0 citations50
US7619112B2Nov 17, 2009

Optical resolution of 3-carbamoylmethyl-5-methyl hexanoic acid

TEVA PHARMA0 citations50

TEVA GYOGYSZERGYAR ZARTKOERUEE

3 patents

TEVA GYOGYSZERGYAR ZARTKOERUEN

2 patents

CORUS PHARMA INC

1 patent

BIOGAL GYOGYSZERGYAR

1 patent

CORUS PHARMA

1 patent

TEVA PHARMACEUICAL IND LTD

1 patent